BioWisdom Limited

BioWisdom Limited

August 16, 2007 04:08 ET

BioWisdom Expands Commercial Activities With Appointment of Michael Stapleton as Chief Business Officer

LONDON, UNITED KINGDOM--(Marketwire - Aug. 16, 2007) - BioWisdom Limited (BioWisdom), a leader in the provision of healthcare software and intelligence to the pharmaceutical industry, today announced plans to expand its global sales and marketing activities under the direction of Michael Stapleton Ph.D.

Dr. Stapleton has more than 20 years experience in the field of scientific software and informatics. He was most recently Vice President of Global Marketing and eBusiness at Invitrogen responsible for the industry-leading web, bioinformatics and eCommerce activities. Prior to Invitrogen, Dr. Stapleton spent 11 years at Accelrys. In particular, as Chief Operating Officer, he was responsible for launching Accelrys in 2001 as a result of the integration of Molecular Simulations, Synopsys, Oxford Molecular Group and Genetics Computer Group. Dr. Stapleton has a Ph.D. in chemistry and has undertaken research at Cornell University and British Petroleum.

"BioWisdom's unique selling point has been its ability to work alongside the scientific community and design bespoke intelligence systems. We aim to build aggressively our business through sales and M&A and I am confident that Michael's considerable experience of the life sciences software industry will bring significant value to these activities," said Gordon Smith Baxter, CEO of BioWisdom.

Michael Stapleton added, "In the last year, BioWisdom has brought together an impressive portfolio of leading edge capabilities for the pharmaceutical software industry, now including the Sofia platform, SRS and OmniViz. I am looking forward to joining Gordon and the impressive team at BioWisdom to drive growth and maximise value."

-Ends-

Notes to Editors

ABOUT BIOWISDOM LTD

BioWisdom delivers intelligence for the Healthcare Industry and helps clients to navigate the complex scientific and commercial issues involved in developing successful healthcare products. The company provides a powerful suite of software tools for the acquisition, integration, visualization and high value analysis of healthcare intelligence. The BioWisdom team combines extensive experience of the pharmaceutical and biotechnology industries with proven expertise in life science software development.

For more information, please visit www.biowisdom.com.

Contact Information